Cargando…

Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series

Detalles Bibliográficos
Autores principales:	ten Hagen, Alexander, Habermann, Elisa, Hermann, Sandra, Burmester, Gerd R, Biesen, Robert, Albach, Fredrik N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729842/ https://www.ncbi.nlm.nih.gov/pubmed/36597976 http://dx.doi.org/10.1136/rmdopen-2022-002567

Ejemplares similares

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
por: Frommert, Leonie Maria, et al.
Publicado: (2022)

Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases
por: Arumahandi de Silva, Amanthi Nadira, et al.
Publicado: (2022)

Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients
por: ten Hagen, Alexander, et al.
Publicado: (2023)

Recovery of hearing loss, depression and erosive polyarthritis after diagnosis of Whipple’s disease
por: Biesen, Robert, et al.
Publicado: (2023)

Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination
por: Habermann, Elisa, et al.
Publicado: (2022)

Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs
por: Charles-Schoeman, Christina, et al.
Publicado: (2016)

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
por: Listing, Joachim, et al.
Publicado: (2015)

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
por: Emery, P, et al.
Publicado: (2010)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases
por: Najm, Aurélie, et al.
Publicado: (2019)

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists
por: Finckh, Axel, et al.
Publicado: (2012)

Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial
por: Conaghan, Philip G, et al.
Publicado: (2013)

The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel
por: Burmester, Gerd, et al.
Publicado: (2010)

Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease
por: Wiebe, Edgar, et al.
Publicado: (2022)

Changes in work stress among doctors in Norway from 2010 to 2019: a study based on repeated surveys
por: Rosta, Judith, et al.
Publicado: (2020)

Current perspective on rituximab in rheumatic diseases
por: Schioppo, Tommaso, et al.
Publicado: (2017)

Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases
por: Ghanem, Paola, et al.
Publicado: (2023)

Impact of autoimmune rheumatic diseases on birth outcomes: a population-based study
por: Strouse, Jennifer, et al.
Publicado: (2019)

Off-label use of rituximab for systemic lupus erythematosus in Europe
por: Rydén-Aulin, Monica, et al.
Publicado: (2016)

Bacterial vaginosis among women at high risk for HIV in Uganda: high rate of recurrent diagnosis despite treatment
por: Francis, Suzanna C, et al.
Publicado: (2016)

Performance of commercial SARS-CoV-2 wild-type and Omicron BA.1 antibody assays compared with pseudovirus neutralization tests
por: Habermann, E., et al.
Publicado: (2023)

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement
por: Schoels, Monika M, et al.
Publicado: (2013)

Rituximab: B cell depletion: case report
Publicado: (2021)

Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case–control study
por: Gadalla, S M, et al.
Publicado: (2009)

Severe COVID-19 outcomes among patients with autoimmune rheumatic diseases or transplantation: a population-based matched cohort study
por: Marozoff, Shelby, et al.
Publicado: (2022)

Associations between hyponatraemia, volume depletion and the risk of falls in US hospitalised patients: a case–control study
por: Fehlberg, Elizabeth A, et al.
Publicado: (2017)

The effect of repeated methotrexate injections on the quality of life of children with rheumatic diseases
por: Jacobse, Justin, et al.
Publicado: (2018)

Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
Publicado: (2021)

Comanagement with rheumatology and prescription biologics filled during pregnancy in women with rheumatic diseases: a retrospective analysis of US administrative claims data
por: Shridharmurthy, Divya, et al.
Publicado: (2022)

COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study
por: Kim, Yun Kyu, et al.
Publicado: (2023)

A cancer geography paradox? Poorer cancer outcomes with longer travelling times to healthcare facilities despite prompter diagnosis and treatment: a data-linkage study
por: Turner, Melanie, et al.
Publicado: (2017)

Predictors of repeat participation in the NHS bowel cancer screening programme
por: Lo, S H, et al.
Publicado: (2015)

Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations
por: Kedra, Joanna, et al.
Publicado: (2019)

Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider
por: Ritschl, Valentin, et al.
Publicado: (2020)

Poor statistical reporting, inadequate data presentation and spin persist despite editorial advice
por: Diong, Joanna, et al.
Publicado: (2018)

B Cell Depletion: Rituximab in Glomerular Disease and Transplantation
por: Marinaki, S., et al.
Publicado: (2013)

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
por: Strangfeld, Anja, et al.
Publicado: (2021)

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’
por: D’Silva, Kristin M, et al.
Publicado: (2020)

Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Wieczorek, Maud, et al.
Publicado: (2022)

High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan
por: Yamauchi, Hideko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ktvn3qapcu4qjmd6ae1u6e1nbh